☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Gastric Cancer
Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...
February 2, 2022
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China
August 17, 2020
Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastr...
May 27, 2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Orphan Drug Designation for Gastri...
May 22, 2020
Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer
January 23, 2020
OBI Pharma's OBI-999 Receives the US FDA's Orphan Drug Designation to Treat Gastric Cancer
January 21, 2020
Load more...
Back to Home